SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Esther G.M. de Waal, Riemer H.J.A. Slart, Marnix J. Leene, Philip M. Kluin, Edo Vellenga, 18F-FDG PET Increases Visibility of Bone Lesions in Relapsed Multiple Myeloma, Clinical Nuclear Medicine, 2015, 40, 4, 291

    CrossRef

  2. 2
    Franco Dammacco, Giuseppe Rubini, Cristina Ferrari, Angelo Vacca, Vito Racanelli, 18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders, Clinical and Experimental Medicine, 2015, 15, 1, 1

    CrossRef

  3. 3
    N. Withofs, C. Nanni, P. Simoni, S. Fanti, Y. Beguin, J. Caers, Imaging myeloma and related monoclonal plasma cell disorders using MRI, low-dose whole-body CT and FDG PET/CT, Clinical and Translational Imaging, 2015,

    CrossRef

  4. 4
    Regan Ferraro, Ankit Agarwal, Erica L. Martin-Macintosh, Patrick J. Peller, Rathan M. Subramaniam, MR Imaging and PET/CT in Diagnosis and Management of Multiple Myeloma, RadioGraphics, 2015, 35, 2, 438

    CrossRef

  5. 5
    Jasna Mihailovic, Stanley J. Goldsmith, Multiple Myeloma: 18F-FDG-PET/CT and Diagnostic Imaging, Seminars in Nuclear Medicine, 2015, 45, 1, 16

    CrossRef

  6. 6
    Francesca Patriarca, Francesca Carobolante, Elena Zamagni, Vittorio Montefusco, Benedetto Bruno, Emanuaela Englaro, Cristina Nanni, Onelio Geatti, Miriam Isola, Alessandra Sperotto, Silvia Buttignol, Raffaella Stocchi, Paolo Corradini, Michele Cavo, Renato Fanin, The Role of Positron Emission Tomography with 18F-Fluorodeoxyglucose Integrated with Computed Tomography in the Evaluation of Patients with Multiple Myeloma Undergoing Allogeneic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2015,

    CrossRef

  7. 7
    Evangelos Terpos, Nikolaos Kanellias, Krzysztof Giannopoulos, Biology and management of myeloma-related bone disease, Acta Haematologica Polonica, 2014, 45, 2, 107

    CrossRef

  8. 8
    Christos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, Leyun Pan, Caixia Cheng, Klaus Kopka, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss, PET/CT studies of multiple myeloma using 18 F-FDG and 18 F-NaF: comparison of distribution patterns and tracers’ pharmacokinetics, European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41, 7, 1343

    CrossRef

  9. 9
    Silvia Park, Su Jin Lee, Won Jin Chang, Chi Hoon Maeng, Jung Yong Hong, Moon Ki Choi, Young Saing Kim, Chul Won Jung, Jun Ho Jang, Seok Jin Kim, Won Seog Kim, Joon Young Choi, Kihyun Kim, Positive Correlation between Baseline PET or PET/CT Findings and Clinical Parameters in Multiple Myeloma Patients, Acta Haematologica, 2014, 131, 4, 193

    CrossRef

  10. 10
    Elena Zamagni, Cristina Nanni, Paola Tacchetti, Lucia Pantani, Giulia Marzocchi, Beatrice Zannetti, Carolina Terragna, Katia Mancuso, Serena Rocchi, Annalisa Pezzi, Nicoletta Testoni, Stefano Fanti, Michele Cavo, Positron Emission Tomography With Computed Tomography–Based Diagnosis of Massive Extramedullary Progression in a Patient With High-Risk Multiple Myeloma, Clinical Lymphoma Myeloma and Leukemia, 2014, 14, 3, e101

    CrossRef

  11. 11
    Giorgio Treglia, Luca Giovanella, Barbara Muoio, Carmelo Caldarella, Solitary Plasmacytoma of the Sternum Mimicking Bone Metastasis in a Patient with a History of Breast Cancer Evaluated by F-18-FDG PET/CT, Nuclear Medicine and Molecular Imaging, 2014, 48, 2, 169

    CrossRef

  12. 12
    Charles Mesguich, Reza Fardanesh, Lawrence Tanenbaum, Ajai Chari, Sundar Jagannath, Lale Kostakoglu, State of the art imaging of multiple myeloma: Comparative review of FDG PET/CT imaging in various clinical settings, European Journal of Radiology, 2014, 83, 12, 2203

    CrossRef

  13. 13
    Annamaria Brioli, Gareth J Morgan, Brian Durie, Elena Zamagni, The utility of newer imaging techniques as predictors of clinical outcomes in multiple myeloma, Expert Review of Hematology, 2014, 7, 1, 13

    CrossRef

  14. 14
    S. Chua, A. Groves, Biomedical Imaging, 2014,

    CrossRef

  15. 15
    K Duncan, T R Rosean, V S Tompkins, A Olivier, R Sompallae, F Zhan, G Tricot, M R Acevedo, L L B Ponto, S A Walsh, L T Tygrett, A J Berger, T Waldschmidt, H C Morse, J J Sunderland, S Janz, 18F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib, Blood Cancer Journal, 2013, 3, 11, e165

    CrossRef

  16. 16
    Yuji Nakamoto, Kensuke Kurihara, Masatoshi Nishizawa, Kouhei Yamashita, Koya Nakatani, Tadakazu Kondo, Akifumi Takaori-Kondo, Kaori Togashi, Clinical value of 11C-methionine PET/CT in patients with plasma cell malignancy: comparison with 18F-FDG PET/CT, European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40, 5, 708

    CrossRef

  17. 17
    Ankit Agarwal, Alin Chirindel, Bhartesh A. Shah, Rathan M. Subramaniam, Evolving Role of FDG PET/CT in Multiple Myeloma Imaging and Management, American Journal of Roentgenology, 2013, 200, 4, 884

    CrossRef

  18. 18
    Bhasker Koppula, Justin Kaptuch, Christopher J. Hanrahan, Imaging of Multiple Myeloma: Usefulness of MRI and PET/CT, Seminars in Ultrasound, CT and MRI, 2013, 34, 6, 566

    CrossRef

  19. 19
    Johannes Czernin, Martin Allen-Auerbach, David Nathanson, Ken Herrmann, PET/CT in Oncology: Current Status and Perspectives, Current Radiology Reports, 2013, 1, 3, 177

    CrossRef

  20. 20
    Patrick J. Peller, Role of Positron Emission Tomography/Computed Tomography in Bone Malignancies, Radiologic Clinics of North America, 2013, 51, 5, 845

    CrossRef

  21. 21
    Giuseppe Lucio Cascini, Carmela Falcone, Domenico Console, Antonino Restuccia, Marco Rossi, Antonello Parlati, Oscar Tamburrini, Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study, La radiologia medica, 2013, 118, 6, 930

    CrossRef

  22. 22
    A. Cotten, T. Facon, X. Leleu, Imagerie Musculosquelettique : Pathologies Générales, 2013,

    CrossRef

  23. 23
    P. Spinnato, A. Bazzocchi, A. Brioli, C. Nanni, E. Zamagni, U. Albisinni, M. Cavo, S. Fanti, G. Battista, E. Salizzoni, Contrast enhanced MRI and 18F-FDG PET-CT in the assessment of multiple myeloma: A comparison of results in different phases of the disease, European Journal of Radiology, 2012, 81, 12, 4013

    CrossRef

  24. 24
    Carmelo Caldarella, Maria Antonietta Isgrò, Ivan Treglia, Giorgio Treglia, Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma?, International Journal of Hematology, 2012, 96, 6, 685

    CrossRef

  25. 25
    Carmelo Caldarella, Giorgio Treglia, Maria Antonietta Isgrò, Ivan Treglia, Alessandro Giordano, The Role of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Evaluating the Response to Treatment in Patients with Multiple Myeloma, International Journal of Molecular Imaging, 2012, 2012, 1

    CrossRef

  26. 26
    Elena Zamagni, Michele Cavo, The role of imaging techniques in the management of multiple myeloma, British Journal of Haematology, 2012, 159, 5